Holen Sie sich die Stockscreener-App
2.95
6.05%
-0.19
Handel nachbörslich:
2.95
Schlusskurs vom Vortag:
$3.14
Offen:
$3.02
24-Stunden-Volumen:
53,546
Relative Volume:
1.03
Marktkapitalisierung:
$89.94M
Einnahmen:
$4.01M
Nettoeinkommen (Verlust:
$-38.53M
KGV:
-2.3413
EPS:
-1.26
Netto-Cashflow:
$-32.27M
1W Leistung:
-8.95%
1M Leistung:
-11.94%
6M Leistung:
-58.16%
1J Leistung:
-64.92%
1-Tages-Spanne:
$2.92
$3.18
1-Wochen-Bereich:
$2.92
$3.31
52-Wochen-Spanne:
$2.92
$9.96
Xbiotech Inc Stock (XBIT) Company Profile
Firmenname
Xbiotech Inc
Sektor
Branche
Telefon
512-386-2900
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Vergleichen Sie XBIT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.95 | 89.94M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-04-21 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-06-28 | Bestätigt | Noble Financial | Buy |
Xbiotech Inc Aktie (XBIT) Neueste Nachrichten
XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat
XBiotech Announces Board Member Retirement - TipRanks
XBiotech (NASDAQ:XBIT) Share Price Crosses Above 50-Day Moving AverageHere's Why - MarketBeat
Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results - MarketBeat
Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView
Stocks Rally as US Government Shutdown Risks Recede - TradingView
Tariff Worries Pressure Stocks - TradingView
XBiotech Inc.'s (NASDAQ:XBIT) 18% gain last week benefited both retail investors who own 49% as well as insiders - Simply Wall St
XBIT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of XBiotech Inc. Shareholders Who Lost Money - ACCESS Newswire
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against XBiotech, Inc. (XBIT) and Lead Plaintiff Deadline: February 1, 2016 - ACCESS Newswire
Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire
XBiotech Inc. (NASDAQ:XBIT) Sees Large Growth in Short Interest - MarketBeat
Head to Head Contrast: Aurinia Pharmaceuticals (NASDAQ:AUPH) and XBiotech (NASDAQ:XBIT) - Armenian Reporter
XBiotech stock plunges to 52-week low, touches $3.03 - Investing.com India
XBiotech stock plunges to 52-week low, touches $3.03 By Investing.com - Investing.com Canada
Head-To-Head Analysis: Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. XBiotech (NASDAQ:XBIT) - Defense World
Investing in XBiotech Inc (XBIT) might be a great opportunity, but the stock is a bit overvalued - US Post News
XBiotech Inc. (NASDAQ:XBIT) Short Interest Update - Defense World
XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider
XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider
Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World
Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.
XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance
Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World
XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks
Franklin Resources Inc. Trims Stock Holdings in JD.com, Inc. (NASDAQ:JD) - Defense World
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):